A Phase 1 Trial of Autologous Macrophage Therapy for Liver Cirrhosis
Therapies to reduce liver fibrosis and stimulate organ regeneration are urgently needed. We conducted a first-in-human, phase 1 dose-escalation trial of autologous macrophage therapy in nine adults with cirrhosis and a Model for End-Stage Liver Disease (MELD) score of 10-16 (ISRCTN 10368050). Groups…
Journal:
Authors:
- Moroni F,
- Dwyer BJ,
- Graham C,
- Pass C,
- Bailey L,
- Ritchie L,
- Mitchell D,
- Glover A,
- Lauire A,
- Doig S,
- Hargreaves E,
- Fraser AR,
- Turner ML,
- Cambpell JDM,
- McGowan NWA,
- Barry J,
- Moore JK,
- Hayes PC,
- Leeming DJ,
- Nielsen MJ,
- Musa K,
- Fallowfield JA,
- Forbes SJ,
Translational Biomarkers and Ex Vivo Models of Joint Tissues as a Tool for Drug Development in Rheumatoid Arthritis
OBJECTIVE:
Rheumatoid arthritis (RA) is a chronic, autoimmune and degenerative joint disease leading to disability, reduced life quality, and increased mortality. Although several synthetic and biological disease modifying anti-rheumatic drugs (DMARDs) are available, there is still a medical need f…
Journal:
Authors:
- Kjelgaard-Petersen CF,
- Platt A,
- Braddock M,
- Jenkins MA,
- Musa K,
- Graham E,
- Gantzel T,
- Slynn G,
- Weinblatt ME,
- Karsdal MA,
- Thudium CS,
- Bay-Jensen AC,
Investigating the Robustness and Diagnostic Potential of Extracellular Matrix Remodelling Biomarkers in Alkaptonuria
BACKGROUND AND AIM:
Alkaptonuria (AKU) clinical manifestations resemble severe arthritis. The Suitability of Nitisinone in Alkaptonuria 1 (SONIA 1) study is a dose-finding trial for nitisinone treatment of AKU patients. We tested a panel of serum and urinary biomarkers reflecting extracellular matr…
Journal:
Authors:
- Genovese F,
- Siebuhr AS,
- Musa K,
- Gallagher JA,
- Milan AM,
- Karsdal MA,
- Rovensky J,
- Bay-Jensen AC,
- Ranganath LR,